Human glutathione S-transferase μ (GSTμ) deficiency as a marker for the susceptibility to bladder and larynx cancer among smokers
References (22)
- et al.
Variations in the glutathione S-transferase subunits expressed in human livers
Biochim. Biophys. Acta
(1986) - et al.
Aryl hydrocarbon hydroxylase inducibility and laryngeal carcinomas
Lancet
(1976) The role of glutathione and glutathione S-transferaee in the metabolism of chemical carcinogens and other electrophilic agents
Adv. Cancer. Res.
(1979)- et al.
Immunohistochemical localization of human urinary bladder glutathione S-transferases
Biochim. Biophys. Acta
(1991) - et al.
The trans-stilbene oxide-active glutathione transferase in human mononuclear leukocytes is identical with the hepatic glutathione transferase μ
Biochem. J.
(1987) - et al.
Human glutathione S-transferase deficiency as a marker of susceptibility to epoxide-induced cytogenetic damage
Cancer Res.
(1990) - et al.
A glutathione transferase in human leukocytes as a marker for the susceptibility to lung cancer
Carcinogenesis
(1986) - et al.
Isoenzyme(s) of glutathione transferase (class Mu) as a marker for the susceptibility to lung cancer: a follow up study
Carcinogenesis
(1990) - et al.
Smoking and cancer of the lower urinary tract
N. Engl. J. Med.
(1971) - et al.
Risk factors for laryngeal cancer
Cancer
(1987)
The epidemiology of bladder cancer. A second look
Cancer
Cited by (174)
Experimental study of A66G-single nucleotide polymorphism in the MTRR gene and acute myeloid leukemia
2023, Journal of King Saud University - ScienceCitation Excerpt :Furthermore, elderly AML patients are poorly tolerated and contagious (Yuan et al., 2021). According to the French and American classifications, AML is divided into eight subtypes, M0-M7, based on the type of leukemia that develops and the degree of maturity of the leukemia (Lafuente et al., 1993). Although many AML experts prefer the 3 + 7 regimen, some do not.
Crocin mitigates carbon tetrachloride-induced liver toxicity in rats
2015, Journal of Taibah University Medical SciencesAssociation of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility
2013, Urologic Oncology: Seminars and Original InvestigationsCitation Excerpt :A few studies demonstrated nonsignificant diminished risk of bladder cancer with GSTT1 null genotype [15,19,20] nonetheless; some other studies demonstrated increased risk of bladder cancer with GSTT1 null genotype [21,22]. GSTMI and GSTTI null genotypes have decreased capacity to detoxify certain carcinogens and have been linked with increased risks for developing bladder cancer [23,24]. The GSTP1313 A/G polymorphism at the nucleotide level results in an amino acid variation of isoleucine/valine at codon 105 in the protein.
Glutathione-S-transferase M1 and T1 genes and gastric cancer: A case control study in North Indian population
2011, GeneCitation Excerpt :GSTM1 and/or GSTT1 has also been detected in various other cancers. A number of studies have shown GSTM1 null genotype associated increased risk for developing lung cancer (Seidegard et al., 1990; Nakajima et al., 1995), for bladder (Bell et al., 1993; Lafuente et al., 1993). GSTT1 was also found to be associated with increased risk of various cancers like bladder cancer (McGrath et al., 2006).
Effect of genetic polymorphism of GSTM1 and GSTT1 genotypes on cytogenetic biomarkers among coaltar workers
2011, Environmental Toxicology and PharmacologyCitation Excerpt :The null genotypes of GST micro (GSTM1) and GST theta (GSTT1) have attracted attention because of their more susceptibility towards various types of cancers (Kempkes et al., 1996; Rebbeck, 1997; Ahrens and Merletti, 1998; Strange and Fryer, 1999). Homozygous deletions of GSTM1 (GSTM1*2) have been associated with higher risk of laryngeal, lung, bladder, colon and gastrointestinal cancers (Hayashi et al., 1992; Lafuente et al., 1993; Brockmoller et al., 1994; Chenevix Trench et al., 1995; Katoh et al., 1996). The null genotype of GSTT1 (GSTT1*2) has been reported to be associated with an increased risk of brain (Elexpuru Camiruaga et al., 1995) and colorectal cancer (Deakin et al., 1996).